Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Novel Cell Line, Tnet-2, Derived from "Triple-Negative" Essential Thrombocythemia

Satoru Aoyama, MD MMSc, Toshikage Nagao, MD PhD, Shunichiro Yasuda, MD, Daisuke Watanabe, MD, Hiroki Akiyama, MD, Shinya Ishida, MD, Ayako Nogami, MD, PhD, Yoshihiro Umezawa, MD, Ken Watanabe, MD PhD, Masahide Yamamoto, MD PhD, Osamu Miura, MD, PhD, Norihiko Kawamata, MD

Blood (2018) 132 (Supplement 1): 5493.

https://doi.org/10.1182/blood-2018-99-114457

Published: 2018

Journal Articles

Tax-Targeting Dendritic Cell Therapy for ATL: A Phase Ia/Ib Clinical Study

Motoaki Shiratsuchi, MDPhD, Tetsuya Fukuda, MD PhD, Tadafumi Iino, MD PhD, Atsuhiko Hasegawa, PhD, Jun-ichirou Yasunaga, MD PhD, Ken Watanabe, MD PhD, Akie Hirata, MD PhD, Hayato Utsunomiya, MD, Hirofumi Ohno, MD, Takashi Ishida, MD PhD, Koichi Akashi, MD PhD, Masao Matsuoka, MDPhD, Mari Kannagi, MD PhD, Youko Suehiro, MDPhD

Blood (2018) 132 (Supplement 1): 1649.

https://doi.org/10.1182/blood-2018-99-113315

Published: 2018

Journal Articles

High-Throughput Sequencing of IgG B-Cell Receptors Reveals the Frequent Usage of the Rearranged IGHV4-28//IGHJ4 Gene in Primary Immune Thrombocytopenia in Adults

Naohito Fujishima, MD, Masaru Togashi, MD PhD, Ryo Hasegawa, MD, Ken Watanabe, MD, Akiko Saga, MD PhD, Ayumi Omokawa, MD PhD, Tomoo Saga, MD PhD, Shigeharu Ueki, MD PhD, Naoto Takahashi, Kazutaka Kitaura, DVM, PhD, Ryuji Suzuki, DVM, PhD, Makoto Hirokawa, MD PhD

Blood (2017) 130 (Supplement 1): 3582.

https://doi.org/10.1182/blood.V130.Suppl_1.3582.3582

Published: 2017

Journal Articles

An Increase in Baseline Level of Urinary Liver-Type Fatty Acid-Binding Protein Linked with Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation

Naoki Shingai, MD, Taku Morito, MD PhD, Shuntaro Ikegawa, MD, Keita Yamamoto, MD, Yutaro Hino, MD, Kaito Harada, MD, Aiko Igarashi, MD, Ken Watanabe, MD PhD, Yasushi Senoo, MD, Yuho Najima, MDPhD, Noriko Doki, MD PhD, Takeshi Kobayashi, MD, Kazuhiko Kakihana, MD PhD, Kazuteru Ohashi, MD PhD, Hisashi Sakamaki, MDPhD, Minoru Ando, MD PhD

Blood (2014) 124 (21): 3861.

https://doi.org/10.1182/blood.V124.21.3861.3861

Published: 2014

Journal Articles

Clinical Impact of CD25 Expression of Leukemic Blasts on Subsequent Transplant Outcomes in Patients with Refractory or Relapsed Acute Myeloid Leukemia

Shuntaro Ikegawa, MD, Noriko Doki, MD PhD, Keita Yamamoto, MD, Yutaro Hino, MD, Kaito Harada, MD, Naoki Shingai, MD, Ken Watanabe, MD PhD, Yasushi Senoo, MD, Aiko Igarashi, MD, Yuho Najima, MDPhD, Takeshi Kobayashi, MD, Kazuhiko Kakihana, MD PhD, Hisashi Sakamaki, MDPhD, Kazuteru Ohashi, MD PhD

Blood (2014) 124 (21): 2589.

https://doi.org/10.1182/blood.V124.21.2589.2589

Published: 2014

NARROW

A Novel Cell Line, Tnet-2, Derived from "Triple-Negative" Essential Thrombocythemia

Tax-Targeting Dendritic Cell Therapy for ATL: A Phase Ia/Ib Clinical Study

High-Throughput Sequencing of IgG B-Cell Receptors Reveals the Frequent Usage of the Rearranged IGHV4-28//IGHJ4 Gene in Primary Immune Thrombocytopenia in Adults

An Increase in Baseline Level of Urinary Liver-Type Fatty Acid-Binding Protein Linked with Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Impact of CD25 Expression of Leukemic Blasts on Subsequent Transplant Outcomes in Patients with Refractory or Relapsed Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

A Novel Cell Line, Tnet-2, Derived from "Triple-Negative" Essential Thrombocythemia

Tax-Targeting Dendritic Cell Therapy for ATL: A Phase Ia/Ib Clinical Study

High-Throughput Sequencing of IgG B-Cell Receptors Reveals the Frequent Usage of the Rearranged IGHV4-28//IGHJ4 Gene in Primary Immune Thrombocytopenia in Adults

An Increase in Baseline Level of Urinary Liver-Type Fatty Acid-Binding Protein Linked with Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Impact of CD25 Expression of Leukemic Blasts on Subsequent Transplant Outcomes in Patients with Refractory or Relapsed Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only